Dr Dinesh Pendharkar highlights how CAR T–cell therapy is reshaping cancer care in India by equipping the immune system with ...

A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...

Researchers have discovered how an inflammatory feedback loop initiated as cancer cells die helps cancer hijack immune responses in order to spread.

A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...

A new machine learning approach identifies cellular senescence at single-cell resolution across varying cell types and tissue ...

Scientists at Nagoya University in Japan studied what happens when macrophages—a type of immune cell—encounter dying cancer cells in tumors and discovered a mechanism that accelerates tumor growth.

During early drug development and preclinical development, researchers use in vitro cultured lymphocytes to induce cytokine ...

Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop diabetes after immunotherapy.

A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...

The growing prevalence of chronic diseases is a major factor driving revenue growth in the natural killer (NK) cell ...